Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Galenfeha, Inc.
SIC 8711 · Services-Engineering Services
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Galenfeha, Inc.
SIC 8711 · Services-Engineering Services
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Galenfeha, Inc.
SIC 8711 · Services-Engineering Services
Notes
Support
about
terms
$
NGHI
Galenfeha, Inc.
CIK:
0001574676
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.24.3
Consolidated Statements of Operations (Unaudited) - USD ($)
1 Months Ended
2 Months Ended
3 Months Ended
Jan. 28, 2018
Mar. 31, 2018
Mar. 31, 2019
Successor [Member]
Revenues
$ 708,126
$ 1,007,082
Less: Cost of Sales
206,395
264,433
Operating Expenses:
General and administrative
90,994
351,599
Payroll expenses
178,117
302,343
Professional fees
25,699
67,876
Depreciation and amortization expense
54,784
39,929
Total operating expenses
349,594
761,747
Income (loss) from operations
152,137
(19,098)
Other (expense) income:
Miscellaneous income (expense)
667
(1,391)
Realized loss on sale of investments
(7,590)
(10,994)
Unrealized gain (loss) on investments
(9,912)
33,295
Interest expense
(66,834)
(177,285)
Gain (loss) on derivative instruments
102,604
(77,272)
Total other (expense) income
18,935
(233,647)
Net income (loss)
$ 171,072
$ (252,745)
Net income per share, basis (in dollars per share)
$ 0.00
$ (0.00)
Net income per share, diluted (in dollars per share)
$ 0.00
$ (0.00)
Weighted average number of common shares outstanding, basic (in shares)
72,153,253
89,929,857
Weighted average number of common shares outstanding, diluted (in shares)
72,153,253
89,929,857
Predecessor [Member]
Revenues
$ 412,416
Less: Cost of Sales
45,626
Operating Expenses:
General and administrative
107,031
Payroll expenses
64,672
Professional fees
375
Depreciation and amortization expense
27,631
Total operating expenses
199,709
Income (loss) from operations
167,081
Other (expense) income:
Miscellaneous income (expense)
Realized loss on sale of investments
Unrealized gain (loss) on investments
Interest expense
(9,969)
Gain (loss) on derivative instruments
Total other (expense) income
(9,969)
Net income (loss)
$ 157,112
v3.24.3
Consolidated Statements of Cash Flows (unaudited) - USD ($)
1 Months Ended
2 Months Ended
3 Months Ended
11 Months Ended
Jan. 28, 2018
Mar. 31, 2018
Mar. 31, 2019
Dec. 31, 2018
Successor [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)
$ 171,072
$ (252,745)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
54,784
39,929
(Gain) Loss on derivative instruments
(102,604)
77,272
Amortization for debt discounts on notes payable and convertible notes
30,956
144,860
Amortization of right of use assets, operating leases
17,679
Bad debt expense
144,658
Realized losses on investments
7,590
10,994
Unrealized (gains) losses on investments
9,912
(33,295)
Changes in operating assets and liabilities:
Accounts receivable
62,391
(313,333)
Due from related party
(4,000)
Inventory
(60,000)
7,227
Prepaid expenses and other current assets
(93,686)
Accounts payable and accrued liabilities
(41,068)
10,125
Right of use liabilities, operating leases
(19,679)
Net cash provided by (used in) operating activities
35,347
(166,308)
CASH FLOWS FROM INVESTING ACTIVITIES
Repurchase and cancellation of common shares
(913)
Sale and purchases of investments, net
30,418
28,451
Cash assumed in acquisition of subsidiary
171,703
Net cash provided by (used in) investing activities
201,208
28,451
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from lines of credit
108,030
657,000
Payments on lines of credit
(656,423)
Payments on other loans payable
(100,348)
Payments on notes payable and capital leases
(144,861)
(48,721)
Proceeds on liabilities due to officer and related parties
300,000
50,000
Payments on liabilities due to officer and related parties
(28,500)
(25,000)
Principal payments on convertible debenture contracts
(21,840)
Payments on margin loan
(14,203)
Net cash provided by (used in) financing activities
98,278
(23,144)
CHANGE IN CASH AND CASH EQUIVALENTS
334,833
(161,001)
Cash and cash equivalents at beginning of period
22,162
181,645
$ 22,162
Cash and cash equivalents at end of period
356,995
20,644
$ 181,645
Cash paid for :
Interest
34,787
18,854
Income Taxes
Non-Cash Transactions
Common stock issued for debt conversion
12,420
133,000
Derivative liability extinguished on conversion
55,938
169,503
Debt discount from issuance of new derivative liabilities
182,958
Initial recognition of ROU assets and liabilities due to adoption of ASC 842
139,048
Finance leases reclassified out of notes payable
260,137
Preferred Series B shares converted into common shares
15,348
Preferred Series B shares converted into Preferred Series A shares
12,000
Fixed assets purchased through accounts and notes payable
$ 65,549
Predecessor [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)
$ 157,112
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
27,631
(Gain) Loss on derivative instruments
Amortization for debt discounts on notes payable and convertible notes
Amortization of right of use assets, operating leases
Bad debt expense
Realized losses on investments
Unrealized (gains) losses on investments
Changes in operating assets and liabilities:
Accounts receivable
(284,592)
Due from related party
18,000
Inventory
Prepaid expenses and other current assets
Accounts payable and accrued liabilities
35,930
Right of use liabilities, operating leases
Net cash provided by (used in) operating activities
(45,919)
CASH FLOWS FROM INVESTING ACTIVITIES
Repurchase and cancellation of common shares
Sale and purchases of investments, net
Cash assumed in acquisition of subsidiary
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from lines of credit
627,147
Payments on lines of credit
(378,897)
Payments on other loans payable
Payments on notes payable and capital leases
(27,415)
Proceeds on liabilities due to officer and related parties
35,000
Payments on liabilities due to officer and related parties
(38,561)
Principal payments on convertible debenture contracts
Payments on margin loan
Net cash provided by (used in) financing activities
217,274
CHANGE IN CASH AND CASH EQUIVALENTS
171,355
Cash and cash equivalents at beginning of period
348
Cash and cash equivalents at end of period
171,703
Cash paid for :
Interest
7,725
Income Taxes
Non-Cash Transactions
Common stock issued for debt conversion
Derivative liability extinguished on conversion
Debt discount from issuance of new derivative liabilities
51,853
Initial recognition of ROU assets and liabilities due to adoption of ASC 842
Finance leases reclassified out of notes payable
Preferred Series B shares converted into common shares
Preferred Series B shares converted into Preferred Series A shares
Fixed assets purchased through accounts and notes payable
v3.24.3
Consolidated Balance Sheets (Unaudited) - Successor [Member] - USD ($)
Mar. 31, 2019
Dec. 31, 2018
CURRENT ASSETS
Cash and cash equivalents
$ 20,644
$ 181,645
Marketable securities
102,000
108,150
Accounts receivable
983,941
815,266
Inventory
157,751
164,978
Total current assets
1,264,336
1,270,039
Property and equipment, net of accumulated depreciation
758,999
733,379
Right of use assets, operating leases
103,369
Goodwill
286,497
286,497
TOTAL ASSETS
2,413,201
2,289,915
CURRENT LIABILITIES
Accounts payable and accrued liabilities
485,379
492,805
Lines of credit payable
640,418
639,841
Note payable
148,602
316,546
Convertible notes payable, net of discount
11,409
182,507
Short-term non-secured debt
60,000
60,000
Due to officer and related parties
352,144
327,144
Right of use liabilities, operating leases, current portion
88,025
Right of use liabilities, finance leases, current portion
162,952
Derivative liabilities
90,727
Total current liabilities
2,039,656
2,018,843
Right of use liabilities, operating leases
31,344
Right of use liabilities, finance leases
75,720
Long term notes payable
240,216
294,565
Total liabilities
2,386,936
2,313,408
STOCKHOLDERS’ EQUITY (DEFICIT)
Common stock Authorized: 150,000,000 common shares, $0.001 par value, 95,944,216 and 72,300,000 issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
95,945
72,300
Additional paid-in capital
4,003,287
3,709,081
Accumulated deficit
(4,092,267)
(3,839,522)
Total stockholders’ equity (deficit)
26,265
(23,493)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
2,413,201
2,289,915
Preferred Stock [Member] | Preferred Class A [Member]
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock
19,300
7,300
Preferred Stock [Member] | Preferred Class B [Member]
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock
$ 27,348